%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Normann Steiner, Udo Müller, Roman Hajek, Sabina Sevcikova, Bojana Borjan, Karin Jöhrer, Georg Göbel, Andreas Pircher, Eberhard Gunsilius
The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref004)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref005)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref004)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref006)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref007)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref008)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref009)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref010)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0202045.ref011)>>
endobj
27 0 obj
<>/Border[0 0 0]/A 28 0 R>>
endobj
28 0 obj
<>
endobj
14 0 obj
[29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R]
endobj
29 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 560.6144 m
199.9998 560.6144 l
199.9998 561.1144 l
575.9997 561.1144 l
f*
0.83 0.64 0.02 0 k
380.2961 445.9465 m
385.0583 445.9465 l
h
f*
375.6472 406.9417 m
380.4094 406.9417 l
h
f*
245.0268 367.937 m
249.789 367.937 l
h
f*
402.8031 354.8976 m
407.5087 354.8976 l
h
f*
409.4929 328.9323 m
414.2551 328.9323 l
h
f*
394.9795 289.9276 m
399.7417 289.9276 l
h
f*
234.9354 237.9402 m
239.6976 237.9402 l
h
f*
434.2677 224.9008 m
439.0299 224.9008 l
h
f*
275.2441 198.9354 m
280.0063 198.9354 l
h
f*
509.3858 172.9134 m
514.148 172.9134 l
h
f*
453.0898 120.926 m
462.6142 120.926 l
h
f*
223.4268 94.9039 m
232.9512 94.9039 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(and)Tj
1.8619 0 Td
(NDMM)Tj
3.312 0 Td
(patients)Tj
3.6821 0 Td
(\(free)Tj
2.2557 0 Td
(carnitine,)Tj
4.2251 0 Td
(acetylcarnitine)Tj
6.3138 0 Td
(,)Tj
0.4953 0 Td
(creatinine,)Tj
4.7741 0 Td
(five)Tj
1.7605 0 Td
(LysoPCs)Tj
4.1833 0 Td
(and)Tj
1.8679 0 Td
(PCs\).)Tj
-34.7317 -1.474 Td
(Pathway)Tj
4.0162 0 Td
(analyses)Tj
4.1236 0 Td
(revealed)Tj
4.0043 0 Td
(a)Tj
0.7639 0 Td
(distinct)Tj
3.3001 0 Td
(metabolic)Tj
4.4459 0 Td
(profile)Tj
2.9063 0 Td
(with)Tj
1.9752 0 Td
(significant)Tj
4.6071 0 Td
(alterations)Tj
4.7741 0 Td
(in)Tj
0.9847 0 Td
(amino)Tj
-35.9014 -1.474 Td
(acid,)Tj
2.3035 0 Td
(lipid,)Tj
2.2438 0 Td
(and)Tj
1.8619 0 Td
(energy)Tj
3.2404 0 Td
(metabolism)Tj
5.2814 0 Td
(in)Tj
0.9847 0 Td
(healthy)Tj
3.4016 0 Td
(volunteers)Tj
4.78 0 Td
(compared)Tj
4.619 0 Td
(to)Tj
1.0503 0 Td
(MGUS/MM)Tj
5.1441 0 Td
(patients.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 647.0929 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 630.1417 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(We)Tj
1.7067 0 Td
(identified)Tj
4.1535 0 Td
(different)Tj
3.7835 0 Td
(metabolic)Tj
4.4399 0 Td
(profiles)Tj
3.3896 0 Td
(in)Tj
0.9787 0 Td
(MGUS)Tj
3.1987 0 Td
(und)Tj
1.8559 0 Td
(MM)Tj
1.8739 0 Td
(patients)Tj
3.6701 0 Td
(in)Tj
0.9787 0 Td
(comparison)Tj
5.3231 0 Td
(to)Tj
1.0384 0 Td
(healthy)Tj
-36.3907 -1.474 Td
(controls.)Tj
3.9565 0 Td
(Thus,)Tj
2.7034 0 Td
(different)Tj
3.7894 0 Td
(metabolic)Tj
4.4519 0 Td
(processes,)Tj
5.0068 0 Td
(potentially)Tj
4.6608 0 Td
(the)Tj
1.5934 0 Td
(immunoregu)Tj
5.5021 0 Td
(lation)Tj
2.5721 0 Td
(by)Tj
1.2651 0 Td
(indolea-)Tj
-35.5015 -1.474 Td
(mine)Tj
2.3631 0 Td
(2,3)Tj
1.5934 0 Td
(dioxygenase-1)Tj
6.642 0 Td
(\(IDO\),)Tj
2.9301 0 Td
(which)Tj
2.7451 0 Td
(is)Tj
0.931 0 Td
(involved)Tj
3.8372 0 Td
(in)Tj
0.9847 0 Td
(cancer)Tj
3.1867 0 Td
(development)Tj
5.8841 0 Td
(and)Tj
1.8619 0 Td
(progression)Tj
-32.9593 -1.474 Td
(supporting)Tj
4.8278 0 Td
(inflammatory)Tj
5.8901 0 Td
(processes)Tj
4.7263 0 Td
(in)Tj
0.9847 0 Td
(the)Tj
1.5993 0 Td
(tumor)Tj
2.7511 0 Td
(microenvironmen)Tj
7.5849 0 Td
(t)Tj
0.4953 0 Td
(and)Tj
1.8679 0 Td
(glutaminolysis,)Tj
6.6957 0 Td
(can)Tj
-37.4231 -1.474 Td
(serve)Tj
2.6377 0 Td
(as)Tj
1.2651 0 Td
(novel)Tj
2.578 0 Td
(promising)Tj
4.4996 0 Td
(therapeutic)Tj
5.1083 0 Td
(targets)Tj
3.2524 0 Td
(in)Tj
0.9787 0 Td
(MM.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 502.9795 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 485.9716 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Multiple)Tj
3.6396 0 Td
(myeloma)Tj
3.9231 0 Td
(\(MM\))Tj
2.6873 0 Td
(still)Tj
1.6384 0 Td
(remains)Tj
3.4412 0 Td
(an)Tj
1.2076 0 Td
(incurable)Tj
3.9684 0 Td
(malignancy)Tj
4.8586 0 Td
(of)Tj
1.0148 0 Td
(antibody-producing)Tj
8.2714 0 Td
(plasma)Tj
-34.6504 -1.2982 Td
(cells.)Tj
2.1429 0 Td
(Monoclonal)Tj
5.0797 0 Td
(gammopathy)Tj
5.4992 0 Td
(of)Tj
1.0148 0 Td
(undetermined)Tj
5.93 0 Td
(significance)Tj
4.9323 0 Td
(\(MGUS\))Tj
3.7247 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6576 0 Td
(common)Tj
3.8438 0 Td
(asymp-)Tj
-33.6697 -1.2983 Td
(tomatic)Tj
3.2654 0 Td
(precursor)Tj
4.0932 0 Td
(state)Tj
2.0353 0 Td
(of)Tj
1.0148 0 Td
(MM.)Tj
2.2337 0 Td
(Process)Tj
3.2258 0 Td
(of)Tj
1.0148 0 Td
(myeloma)Tj
3.9231 0 Td
(initiation)Tj
3.9231 0 Td
(is)Tj
0.8504 0 Td
(mediated)Tj
3.9402 0 Td
(by)Tj
1.1792 0 Td
(interaction)Tj
4.6091 0 Td
(of)Tj
-35.3081 -1.2982 Td
(inherited)Tj
3.8721 0 Td
(genetic)Tj
3.0727 0 Td
(and)Tj
1.7291 0 Td
(environmental)Tj
6.1115 0 Td
(factors)Tj
2.9026 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5988 0 Td
(Clinical)Tj
3.3165 0 Td
(manifestations)Tj
6.0774 0 Td
(of)Tj
1.0148 0 Td
(MM)Tj
2.0069 0 Td
(occur)Tj
2.4718 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
-35.875 -1.304 Td
(proliferation)Tj
5.2667 0 Td
(of)Tj
1.0148 0 Td
(malignant)Tj
4.2803 0 Td
(plasma)Tj
3.033 0 Td
(cells)Tj
1.9219 0 Td
(or)Tj
1.0942 0 Td
(effects)Tj
2.7269 0 Td
(of)Tj
1.0148 0 Td
(aberrant)Tj
3.6056 0 Td
(proteins)Tj
3.515 0 Td
(released)Tj
3.4299 0 Td
(by)Tj
1.1848 0 Td
(myeloma)Tj
-32.0879 -1.2982 Td
(cells.)Tj
2.1429 0 Td
(Most)Tj
2.2791 0 Td
(common)Tj
3.8494 0 Td
(signs)Tj
2.2223 0 Td
(and)Tj
1.7292 0 Td
(symptoms)Tj
4.3596 0 Td
(of)Tj
1.0148 0 Td
(MM)Tj
2.0013 0 Td
(include)Tj
3.1861 0 Td
(hypercalcemia,)Tj
6.2135 0 Td
(renal)Tj
2.2393 0 Td
(function)Tj
-31.2375 -1.2983 Td
(impairment,)Tj
5.21 0 Td
(anemia)Tj
3.1464 0 Td
(and)Tj
1.7292 0 Td
(lytic)Tj
1.9105 0 Td
(bone)Tj
2.2053 0 Td
(disease)Tj
3.0217 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.5988 0 Td
(Major)Tj
2.6815 0 Td
(progress)Tj
3.6 0 Td
(in)Tj
1.0318 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(multiple)Tj
3.5659 0 Td
(mye-)Tj
-34.8545 -1.3039 Td
(loma)Tj
2.228 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(seen)Tj
1.9786 0 Td
(mainly)Tj
2.9877 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(development)Tj
5.4085 0 Td
(of)Tj
1.0148 0 Td
(novel)Tj
2.398 0 Td
(agents,)Tj
2.9764 0 Td
(as)Tj
1.0148 0 Td
(proteasome)Tj
4.8812 0 Td
(inhibitors.)Tj
-31.2772 -1.2983 Td
(Although)Tj
4.0024 0 Td
(survival)Tj
3.3392 0 Td
(of)Tj
1.0148 0 Td
(MM)Tj
2.0013 0 Td
(has)Tj
1.542 0 Td
(increased,)Tj
4.2293 0 Td
(most)Tj
2.2053 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(patients)Tj
3.3675 0 Td
(ultimately)Tj
4.2349 0 Td
(relapse)Tj
2.9991 0 Td
(and)Tj
1.7291 0 Td
(become)Tj
-33.1481 -1.2982 Td
(refractory)Tj
4.1612 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.6044 0 Td
(Therefore,)Tj
4.388 0 Td
(novel)Tj
2.4038 0 Td
(therapeutic)Tj
4.7281 0 Td
(options)Tj
3.2258 0 Td
(are)Tj
1.4513 0 Td
(needed.)Tj
3.3222 0 Td
(Dysregulated)Tj
5.4879 0 Td
(metabolism)Tj
4.9039 0 Td
(has)Tj
-35.6766 -1.304 Td
(been)Tj
2.1203 0 Td
(considered)Tj
4.6034 0 Td
(as)Tj
1.0148 0 Td
(one)Tj
1.6951 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(hallmarks)Tj
4.1556 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.8459 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.5988 0 Td
(The)Tj
1.7801 0 Td
(Warburg)Tj
4.2576 0 Td
(effect)Tj
2.7553 0 Td
(gave)Tj
1.9955 0 Td
(the)Tj
1.4741 0 Td
(first)Tj
-33.8001 -1.2982 Td
(insights)Tj
3.3165 0 Td
(into)Tj
1.8368 0 Td
(the)Tj
1.474 0 Td
(altered)Tj
2.9424 0 Td
(metabolism)Tj
4.9039 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.8459 0 Td
(cells)Tj
1.9162 0 Td
(reporting)Tj
3.9912 0 Td
(that)Tj
1.7801 0 Td
(tumor)Tj
2.744 0 Td
(cells)Tj
1.9218 0 Td
(prefer)Tj
2.6136 0 Td
(aerobic)Tj
-33.3012 -1.2983 Td
(glycolysis)Tj
4.0024 0 Td
(for)Tj
1.389 0 Td
(nutrient)Tj
3.5036 0 Td
(production)Tj
4.7168 0 Td
(and)Tj
1.7292 0 Td
(proliferation)Tj
5.2667 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5987 0 Td
(Recently,)Tj
3.8891 0 Td
(the)Tj
1.4684 0 Td
(field)Tj
1.9729 0 Td
(of)Tj
1.0148 0 Td
(metabolomics)Tj
5.8336 0 Td
(is)Tj
-36.3852 -1.2982 Td
(attracting)Tj
4.0591 0 Td
(considerable)Tj
5.2611 0 Td
(interest)Tj
3.2088 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(novel)Tj
2.3981 0 Td
(methods)Tj
3.685 0 Td
(and)Tj
1.7292 0 Td
(technical)Tj
3.8154 0 Td
(progress,)Tj
3.821 0 Td
(which)Tj
2.6476 0 Td
(enable)Tj
-33.3522 -1.304 Td
(high)Tj
2.0069 0 Td
(quality)Tj
2.9536 0 Td
(measurements)Tj
6.0321 0 Td
(and)Tj
1.7292 0 Td
(contributed)Tj
4.9209 0 Td
(significantly)Tj
5.091 0 Td
(to)Tj
1.0261 0 Td
(a)Tj
0.652 0 Td
(better)Tj
2.5398 0 Td
(understanding)Tj
6.0718 0 Td
(of)Tj
1.0148 0 Td
(meta-)Tj
-34.0382 -1.2982 Td
(bolic)Tj
2.1713 0 Td
(rewiring)Tj
3.617 0 Td
(in)Tj
1.0374 0 Td
(pathological)Tj
5.091 0 Td
(diseases)Tj
3.3789 0 Td
(as)Tj
1.0148 0 Td
(cancer)Tj
2.846 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
1.5987 0 Td
(Metabolic)Tj
4.2179 0 Td
(profiling)Tj
3.702 0 Td
(in)Tj
1.0318 0 Td
(cancer)Tj
2.846 0 Td
(emerges)Tj
3.5093 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
-37.0769 -1.2983 Td
(tool)Tj
1.7744 0 Td
(for)Tj
1.389 0 Td
(the)Tj
1.4683 0 Td
(diagnosis,)Tj
4.1839 0 Td
(classification,)Tj
5.5729 0 Td
(treatment)Tj
4.1329 0 Td
(decisions)Tj
3.9061 0 Td
(and)Tj
1.7348 0 Td
(assessment)Tj
4.6091 0 Td
(of)Tj
1.0148 0 Td
(treatment)Tj
4.1386 0 Td
(efficacy,)Tj
-33.9248 -1.3039 Td
(and)Tj
1.7291 0 Td
(identification)Tj
5.5842 0 Td
(of)Tj
1.0148 0 Td
(novel)Tj
2.4038 0 Td
(therapeutic)Tj
4.7281 0 Td
(targets.)Tj
3.1011 0 Td
(Metabolic)Tj
4.2179 0 Td
(profiling)Tj
3.6964 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1508 0 Td
(performed)Tj
4.4674 0 Td
(in)Tj
1.0375 0 Td
(differ-)Tj
-34.7582 -1.2983 Td
(ent)Tj
1.491 0 Td
(tissue)Tj
2.4548 0 Td
(samples)Tj
3.3845 0 Td
(and)Tj
1.7291 0 Td
(biofluids,)Tj
3.9458 0 Td
(such)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(serum,)Tj
2.948 0 Td
(plasma,)Tj
3.2598 0 Td
(saliva,)Tj
2.6419 0 Td
(urine)Tj
2.3584 0 Td
(and)Tj
1.7291 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.6519 0 Td
(high)Tj
2.007 0 Td
(throughput)Tj
-32.7116 -1.2982 Td
(fashion)Tj
3.1521 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
1.5987 0 Td
(Nevertheless,)Tj
5.4992 0 Td
(metabolomics)Tj
5.8336 0 Td
(reporting)Tj
3.9912 0 Td
(and)Tj
1.7291 0 Td
(data)Tj
1.9105 0 Td
(analysis)Tj
3.3279 0 Td
(is)Tj
0.8504 0 Td
(not)Tj
1.5704 0 Td
(yet)Tj
1.4003 0 Td
(standardized)Tj
-30.8634 -1.304 Td
(and)Tj
1.7291 0 Td
(often)Tj
2.2847 0 Td
(more)Tj
2.3414 0 Td
(technical)Tj
3.8154 0 Td
(oriented)Tj
3.583 0 Td
(and)Tj
1.7291 0 Td
(less)Tj
1.6157 0 Td
(biology)Tj
3.1748 0 Td
(driven)Tj
2.812 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
-21.889 -1.2982 Td
(The)Tj
1.7858 0 Td
(first)Tj
1.8028 0 Td
(metabolic)Tj
4.1499 0 Td
(analysis)Tj
3.3222 0 Td
(of)Tj
1.0148 0 Td
(MM)Tj
2.0069 0 Td
(cells)Tj
1.9219 0 Td
(identified)Tj
4.0592 0 Td
(that)Tj
1.7744 0 Td
(MM)Tj
2.007 0 Td
(depend)Tj
3.1917 0 Td
(on)Tj
1.2756 0 Td
(glucose)Tj
3.1691 0 Td
(and)Tj
1.7348 0 Td
(gluta-)Tj
-34.4123 -1.2983 Td
(mine)Tj
2.279 0 Td
(metabolism)Tj
4.9039 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5987 0 Td
(Higher)Tj
3.0444 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(isoleucine,)Tj
4.4391 0 Td
(arginine,)Tj
3.77 0 Td
(acetate,)Tj
3.1805 0 Td
(phenylalanine,)Tj
6.0661 0 Td
(and)Tj
1.7291 0 Td
(tyro-)Tj
-34.401 -1.3039 Td
(sine,)Tj
2.0466 0 Td
(and)Tj
1.7291 0 Td
(decreased)Tj
4.1329 0 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(3-hydroxybutyrate,)Tj
7.8972 0 Td
(lysine,)Tj
2.744 0 Td
(glutamine,)Tj
4.4787 0 Td
(and)Tj
1.7291 0 Td
(some)Tj
2.3301 0 Td
(lipids)Tj
2.4094 0 Td
(were)Tj
-32.8873 -1.2983 Td
(observed)Tj
3.7927 0 Td
(in)Tj
1.0375 0 Td
(myeloma)Tj
3.9231 0 Td
(patients)Tj
3.3675 0 Td
(at)Tj
0.9525 0 Td
(diagnosis,)Tj
4.1839 0 Td
(but)Tj
1.5533 0 Td
(not)Tj
1.5761 0 Td
(after)Tj
2.0353 0 Td
(achieving)Tj
4.0308 0 Td
(remission)Tj
4.1442 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(].)Tj
1.6044 0 Td
(Bajpai)Tj
2.7043 0 Td
(et)Tj
0.9467 0 Td
(al.)Tj
-35.8523 -1.2982 Td
(showed)Tj
3.2484 0 Td
(that)Tj
1.7802 0 Td
(targeting)Tj
3.7927 0 Td
(glutamine)Tj
4.2463 0 Td
(metabolism)Tj
4.9039 0 Td
(sensitizes)Tj
3.9458 0 Td
(MM)Tj
2.0069 0 Td
(cells)Tj
1.9162 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.474 0 Td
(bcl-2)Tj
2.2223 0 Td
(inhibitor)Tj
3.7814 0 Td
(veneto-)Tj
-34.3443 -1.2983 Td
(clax.)Tj
2.0125 0 Td
(Cellular)Tj
3.3789 0 Td
(metabolic)Tj
4.1442 0 Td
(investigations)Tj
5.726 0 Td
(revealed)Tj
3.5206 0 Td
(LDHA)Tj
2.948 0 Td
(and)Tj
1.7291 0 Td
(HIF1)Tj
/F11 1 Tf
()Tj
/F6 1 Tf
2.9027 0 Td
(as)Tj
1.0148 0 Td
(novel)Tj
2.3981 0 Td
(targets)Tj
2.8743 0 Td
(for)Tj
1.3833 0 Td
(drug)Tj
-34.0325 -1.3039 Td
(resistance)Tj
4.1328 0 Td
(in)Tj
1.0318 0 Td
(MM)Tj
2.007 0 Td
(under)Tj
2.6192 0 Td
(bone)Tj
2.2053 0 Td
(marrow)Tj
3.4072 0 Td
(hypoxic)Tj
3.3846 0 Td
(conditions.)Tj
4.6998 0 Td
(Inhibition)Tj
4.2973 0 Td
(of)Tj
1.0148 0 Td
(LDHA)Tj
2.948 0 Td
(and)Tj
1.7291 0 Td
(HIF1A)Tj
-33.4769 -1.2983 Td
(can)Tj
1.627 0 Td
(restore)Tj
2.9764 0 Td
(sensitivity)Tj
4.2179 0 Td
(to)Tj
1.0261 0 Td
(therapeutic)Tj
4.7339 0 Td
(drugs)Tj
2.4718 0 Td
(such)Tj
2.0579 0 Td
(as)Tj
1.0148 0 Td
(bortezomib)Tj
4.8416 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
2.0749 0 Td
(Ludwig)Tj
3.2315 0 Td
(et)Tj
0.9411 0 Td
(al.)Tj
1.1282 0 Td
(highlights)Tj
-32.3431 -1.2982 Td
(alterations)Tj
4.4106 0 Td
(in)Tj
1.0318 0 Td
(bone)Tj
2.2054 0 Td
(marrow)Tj
3.4072 0 Td
(metabolism)Tj
4.9039 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2019 0 Td
(early)Tj
2.1543 0 Td
(feature)Tj
2.982 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(development)Tj
5.4085 0 Td
(of)Tj
1.0148 0 Td
(MGUS)Tj
3.0387 0 Td
(and)Tj
-35.2627 -1.304 Td
(MM)Tj
2.0069 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.0749 0 Td
(Despite)Tj
3.2485 0 Td
(the)Tj
1.4683 0 Td
(interest)Tj
3.2088 0 Td
(in)Tj
1.0375 0 Td
(metabolomics)Tj
5.8337 0 Td
(of)Tj
1.0148 0 Td
(MM,)Tj
2.228 0 Td
(the)Tj
1.474 0 Td
(role)Tj
1.7688 0 Td
(and)Tj
1.7291 0 Td
(potential)Tj
3.7587 0 Td
(application)Tj
4.6828 0 Td
(in)Tj
-35.5348 -1.2982 Td
(diagnostics,)Tj
4.9039 0 Td
(classification)Tj
5.3461 0 Td
(and)Tj
1.7291 0 Td
(prediction)Tj
4.371 0 Td
(of)Tj
1.0148 0 Td
(therapy)Tj
3.2485 0 Td
(response)Tj
3.736 0 Td
(remains)Tj
3.4412 0 Td
(unclear.)Tj
3.4243 0 Td
(Therefore,)Tj
4.388 0 Td
(this)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 391.6913 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Plasma)Tj
3.5008 0 Td
(metabolic)Tj
4.422 0 Td
(profile)Tj
2.8843 0 Td
(in)Tj
0.978 0 Td
(multiple)Tj
3.5929 0 Td
(myeloma)Tj
4.2166 0 Td
(patients)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.02020)Tj
4.089 0 Td
(45)Tj
0 g
2.0906 0 Td
(August)Tj
3.2882 0 Td
(10,)Tj
1.5874 0 Td
(2018)Tj
34.0302 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(13)Tj
/F9 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(specific)Tj
3.0189 0 Td
(role)Tj
1.6157 0 Td
(of)Tj
0.9496 0 Td
(this)Tj
1.5662 0 Td
(author)Tj
2.6221 0 Td
(is)Tj
0.8362 0 Td
(articulate)Tj
3.3591 0 Td
(d)Tj
0.6945 0 Td
(in)Tj
0.8858 0 Td
(the)Tj
-15.5481 -1.3748 Td
(`author)Tj
2.8204 0 Td
(contributi)Tj
3.515 0 Td
(ons')Tj
1.7859 0 Td
(section.)Tj
/F8 1 Tf
-8.1213 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(We)Tj
1.4457 0 Td
(have)Tj
1.9559 0 Td
(the)Tj
1.3678 0 Td
(following)Tj
-12.9615 -1.3749 Td
(interests.)Tj
3.6142 0 Td
(Mu)Tj
0 Tc
0.8362 0 Td
()Tj
-0.025 Tc
0.3897 0 Td
(ller)Tj
1.3394 0 Td
(Udo)Tj
1.7504 0 Td
(is)Tj
0.8363 0 Td
(employed)Tj
3.848 0 Td
(by)Tj
1.1197 0 Td
(Biocrates)Tj
3.6567 0 Td
(Life)Tj
-17.3906 -1.3748 Td
(Sciences)Tj
3.522 0 Td
(AG.)Tj
1.552 0 Td
(There)Tj
2.3173 0 Td
(are)Tj
1.3749 0 Td
(no)Tj
1.1622 0 Td
(patents,)Tj
3.1677 0 Td
(products)Tj
3.5221 0 Td
(in)Tj
-16.6182 -1.3748 Td
(developm)Tj
3.6283 0 Td
(ent)Tj
1.3748 0 Td
(or)Tj
0.9993 0 Td
(marketed)Tj
3.6992 0 Td
(products)Tj
3.515 0 Td
(to)Tj
0.9496 0 Td
(declare.)Tj
3.104 0 Td
(This)Tj
-17.2702 -1.3748 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4173 0 Td
(alter)Tj
1.8213 0 Td
(the)Tj
1.3677 0 Td
(authors')Tj
3.2386 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(all)Tj
1.0276 0 Td
(the)Tj
-15.8883 -1.3748 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8708 0 Td
(policies)Tj
3.0119 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
1.5874 0 Td
(materials,)Tj
-14.7402 -1.3748 Td
(as)Tj
1.063 0 Td
(detailed)Tj
3.0756 0 Td
(online)Tj
2.4449 0 Td
(in)Tj
0.8858 0 Td
(the)Tj
1.3677 0 Td
(guide)Tj
2.2607 0 Td
(for)Tj
ET
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
BT
12.352 72.3407 Td
(authors.)Tj
ET
Q
endstream
endobj
42 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 46 0 R/Contents 47 0 R/TrimBox[0 0 612 792]>>
endobj
44 0 obj
<>
endobj
48 0 obj
<>
endobj
51 0 obj
<>stream
MinionPro-It 9 `ab]+
W W X ' - 3 > H N T Z ` j q t { +2=CIU[cnz~
"(.9CIOU[elov|&-8>DPV^iuy &+/49@DGLPU[]_ahjmru|
&-4;BIPW^elsz
")07>ELSZahov} %,3:AHOV]dkry#/;JTey ! ( / 6 = D K R Y ` g n u |
$
+
2
9
@
G
N
U
\
c
j
q
x
'.5<CJQX_fmt{ #*18?FMT[bkry
"
)
0
7
>
E
J
O
W
d
q
v
$+29@GNU\cjqx '.5<CJQX_fmt{ #*18?FMT[bipw~
&-4;BIPW^elsz !(/6=DOVcpuz-B\v$<Tdy*5@Tanz!2>O_fmt{ #*18?FMT[bipw~(4@LZk{ "3EU_px!-?IUas $6BN\m
-:EQ]n}
%.7@IR[dmv!*3<ENW`ir{&/8AJS\enw ! * 3 < E N W ` i r { !!
!""commaaccentAbreveAmacronAogonekAEacuteCacuteCcaronCcircumflexCdotaccentDcaronDcroatEbreveEcaronEdotaccentEmacronEngEogonekGbreveGcircumflexGcommaaccentGdotaccentHbarHcircumflexIbreveIJImacronIogonekItildeJcircumflexKcommaaccentLacuteLcaronLcommaaccentLdotNacuteNcaronNcommaaccentObreveOhungarumlautOmacronOslashacuteRacuteRcaronRcommaaccentSacuteScedillaScircumflexScommaaccentTbarTcaronTcommaaccentUbreveUhungarumlautUmacronUogonekUringUtildeWacuteWcircumflexWdieresisWgraveYcircumflexYgraveZacuteZdotaccentIdotaccentabreveamacronaogonekaeacutecacuteccaronccircumflexcdotaccentdcarondcroatebreveecaronedotaccentemacronengeogonekgbrevegcircumflexgcommaaccentgdotaccenthbarhcircumflexibreveijimacroniogonekitildejcircumflexkcommaaccentlacutelcaronlcommaaccentldotnacutencaronncommaaccentobreveohungarumlautomacronoslashacuteracutercaronrcommaaccentsacutescedillascircumflexscommaaccenttbartcarontcommaaccentubreveuhungarumlautumacronuogonekuringutildewacutewcircumflexwdieresiswgraveycircumflexygravezacutezdotaccentkgreenlandiclongsnapostrophetonosdieresistonosAlphaBetaGammaDeltaEpsilonZetaEtaThetaIotaKappaLambdaMuNuXiOmicronPiRhoSigmaTauUpsilonPhiChiPsiOmegaAlphatonosEpsilontonosEtatonosIotatonosIotadieresisOmicrontonosUpsilontonosUpsilondieresisOmegatonosuni1FBBuni1F09uni1F0Duni1F0Buni1F0Funi1FB8uni1FBAuni1FBCuni1F89uni1F8Duni1F8Buni1F8Funi1F88uni1F8Cuni1F8Auni1F8Euni1F08uni1F0Cuni1F0Auni1F0Euni1FB9uni1FC9uni1F19uni1F1Duni1F1Buni1FC8uni1F18uni1F1Cuni1F1Auni1FCBuni1F29uni1F2Duni1F2Buni1F2Funi1FCAuni1FCCuni1F99uni1F9Duni1F9Buni1F9Funi1F98uni1F9Cuni1F9Auni1F9Euni1F28uni1F2Cuni1F2Auni1F2Euni1FDBuni1F39uni1F3Duni1F3Buni1F3Funi1FD8uni1FDAuni1F38uni1F3Cuni1F3Auni1F3Euni1FD9uni1FFBuni1F69uni1F6Duni1F6Buni1F6Funi1FFAuni1FFCuni1FA9uni1FADuni1FABuni1FAFuni1FA8uni1FACuni1FAAuni1FAEuni1F68uni1F6Cuni1F6Auni1F6Euni1FF9uni1F49uni1F4Duni1F4Buni1FF8uni1F48uni1F4Cuni1F4Auni1FECuni1FEBuni1F59uni1F5Duni1F5Buni1F5Funi1FE8uni1FEAuni1FE9alphabetagammadeltaepsilonzetaetathetaiotakappalambdanuxiomicronpirhosigmatauupsilonphichipsiomegaalphatonosepsilontonosetatonosiotatonosiotadieresisomicrontonosupsilontonosupsilondieresisomegatonosiotadieresistonosupsilondieresistonosuni03C2uni0374uni0375uni037Euni03D0uni03DAuni03DEuni03E0uni03F0uni1FBDuni1FBEuni1FC1uni1FCDuni1FCEuni1FCFuni1FDDuni1FDEuni1FDFuni1FEDuni1FEEuni1FFEuni1F00uni1F01uni1F02uni1F03uni1F04uni1F05uni1F06uni1F07uni1F10uni1F11uni1F12uni1F13uni1F14uni1F15uni1F20uni1F21uni1F22uni1F23uni1F24uni1F25uni1F26uni1F27uni1F30uni1F31uni1F32uni1F33uni1F34uni1F35uni1F36uni1F37uni1F40uni1F41uni1F42uni1F43uni1F44uni1F45uni1F50uni1F51uni1F52uni1F53uni1F54uni1F55uni1F56uni1F57uni1F60uni1F61uni1F62uni1F63uni1F64uni1F65uni1F66uni1F67uni1F70uni1F71uni1F72uni1F73uni1F74uni1F75uni1F76uni1F77uni1F78uni1F79uni1F7Auni1F7Buni1F7Cuni1F7Duni1F80uni1F81uni1F82uni1F83uni1F84uni1F85uni1F86uni1F87uni1F90uni1F91uni1F92uni1F93uni1F94uni1F95uni1F96uni1F97uni1FA0uni1FA1uni1FA2uni1FA3uni1FA4uni1FA5uni1FA6uni1FA7uni1FB0uni1FB1uni1FB2uni1FB3uni1FB6uni1FB7uni1FC2uni1FC3uni1FC4uni1FC6uni1FC7uni1FD0uni1FD1uni1FD2uni1FD3uni1FD6uni1FD7uni1FE0uni1FE1uni1FE2uni1FE3uni1FE4uni1FE5uni1FE6uni1FF2uni1FF3uni1FF4uni1FF6uni1FF7uni1FB4uni1FE7uniEFD5anoteleiauni03D1uni03D5uni03D6franclirapesetaEuroafii61289estimatedpartialdiffproductsummationuni2219radicalinfinityintegralapproxequalnotequallessequalgreaterequallozengeuni02C9uniEFEDuniEFEEuniEFF1uniEFF2uniEFF3uniEFF5uniEFF7AcuteCaronDieresisDieresisAcuteDieresisGraveGraveHungarumlautMacroncyrBrevecyrFlexdblGravecyrbrevecyrflexdblgravedieresisacutedieresisgraveuniF635uniF637uniF638uniF639uniF6DCuniF63AuniF63BuniF63CuniF63DuniF63EuniF63FuniF640uniF641uniF642uniF628uniF643uniF644uniF645uniF646uniF647uniF648uniF649uniF64AuniF64BuniF64CuniF64DuniF64EuniF64FuniF650uniF651uniF652uniF653uniF654uniF655uniF656uniF657uniF658uniF659uniF65AuniF65BuniF65CuniF65DuniF65EuniF65FuniF660uniF629uniF62AuniF62BuniF62CuniF62DuniF661uniF662uniF663uniF664uniF665uniF666uniF667uniF668uniF669uniF66AuniF66BuniF66CuniF62EuniF62FuniF630uniF631uniF632uniF66DuniF66EuniF66FuniF670uniF671uniF672uniF673uniF674uniF675uniF676uniF677uniF678uniF679uniF67AuniF67BuniF67CuniF67DuniF67EuniF67FuniF680uniF681uniF682uniF683uniF684uniF685uniF686uniF687uniF688uniF689uniF68AuniF68BuniF68CuniF68DuniF68EuniF68FuniF690uniF691uniF692uniF693uniF694uniF695uniF696uniF697uniF698uniF699uniF69AuniF69BuniF69CuniF69DuniF69EuniF69FuniF6A0uniF6A1uniF6A2uniF6A3uniF6A4uniF6A5uniF6A6uniF6A7uniF6A8uniF6A9uniF6AAuniF6ABuniF6ACuniF6ADuniF6AEuniF6AFuniF6B0uniF6B1uniF6B2uniF6B3uniF6B4uniF6B5uniF6B6uniF6B7uniF6B8uniF6B9uniF6BAuniF6BBuniF6BCuniF6BDuniF633c_hc_kc_tf_bf_f_bf_f_hf_f_kf_f_tf_hf_jf_f_jf_kf_ts_puniFB06T_hlongs_blongs_hlongs_ilongs_klongs_llongs_longsuniFB05longs_longs_ilongs_longs_la.ende.endm.endn.endr.endK.altR.altk.altcaron.altcommaaccent.altpeseta.altAlphaiotasub.altAlphaiotasubasper.altAlphaiotasubasperacute.altAlphaiotasubaspergrave.altAlphaiotasubaspertilde.altAlphaiotasublenis.altAlphaiotasublenisacute.altAlphaiotasublenisgrave.altAlphaiotasublenistilde.altEtaiotasub.altEtaiotasubasper.altEtaiotasubasperacute.altEtaiotasubaspergrave.altEtaiotasubaspertilde.altEtaiotasublenis.altEtaiotasublenisacute.altEtaiotasublenisgrave.altEtaiotasublenistilde.altOmegaiotasub.altOmegaiotasubasper.altOmegaiotasubasperacute.altOmegaiotasubaspergrave.altOmegaiotasubaspertilde.altOmegaiotasublenis.altOmegaiotasublenisacute.altOmegaiotasublenisgrave.altOmegaiotasublenistilde.altEuro.fittedcent.fittedcolonmonetary.fitteddollar.fittedflorin.fittedfranc.fittedlira.fittednumbersign.fittedsterling.fittedyen.fittedEuro.oldstylecolonmonetary.oldstyleestimated.oldstyleflorin.oldstylefranc.oldstylelira.oldstylenumbersign.oldstylesterling.oldstyleyen.oldstylefranc.taboldstylelira.taboldstyleorn.001orn.002orn.003orn.004orn.005orn.006orn.007orn.008orn.009orn.010orn.011orn.012orn.013orn.014orn.015orn.016orn.017orn.018orn.019orn.020orn.021orn.022orn.023A.swashB.swashC.swashD.swashE.swashF.swashG.swashH.swashI.swashJ.swashK.swashL.swashM.swashN.swashO.swashP.swashQ.swashR.swashS.swashT.swashU.swashV.swashW.swashX.swashY.swashZ.swashT_h.swashAacute.swashAbreve.swashAcircumflex.swashAdieresis.swashAgrave.swashAmacron.swashAogonek.swashAring.swashAtilde.swashCacute.swashCcaron.swashCcedilla.swashCcircumflex.swashCdotaccent.swashDcaron.swashDcroat.swashEacute.swashEbreve.swashEcaron.swashEcircumflex.swashEdieresis.swashEdotaccent.swashEgrave.swashEmacron.swashEng.swashEogonek.swashGbreve.swashGcircumflex.swashGcommaaccent.swashGdotaccent.swashHbar.swashHcircumflex.swashIJ.swashIacute.swashIbreve.swashIcircumflex.swashIdieresis.swashIdotaccent.swashIgrave.swashImacron.swashIogonek.swashItilde.swashJcircumflex.swashKcommaaccent.swashLacute.swashLcaron.swashLcommaaccent.swashLdot.swashNacute.swashNcaron.swashNcommaaccent.swashNtilde.swashOacute.swashObreve.swashOcircumflex.swashOdieresis.swashOgrave.swashOhungarumlaut.swashOmacron.swashOslash.swashOslashacute.swashOtilde.swashRacute.swashRcaron.swashRcommaaccent.swashSacute.swashScaron.swashScedilla.swashScircumflex.swashScommaaccent.swashTbar.swashTcaron.swashTcommaaccent.swashT_h.caronswashT_h.commaaccentswashUacute.swashUbreve.swashUcircumflex.swashUdieresis.swashUgrave.swashUhungarumlaut.swashUmacron.swashUogonek.swashUring.swashUtilde.swashWacute.swashWcircumflex.swashWdieresis.swashWgrave.swashYacute.swashYcircumflex.swashYdieresis.swashYgrave.swashZacute.swashZcaron.swashZdotaccent.swashafii10056T_h.caronT_h.commaaccentafii10048afii10074afii10075afii10082afii10192afii10062afii10194afii10193afii10102afii10071afii10041afii10076afii10085afii10103afii10051afii10039afii10037afii10079afii10061afii10059afii10047afii10067afii10049afii10148afii10033afii10094afii10080afii10022afii10145afii10063afii10027afii10070afii10054afii10109afii10036afii10065afii10055afii10068afii10086afii10064afii10096afii10050afii10146afii10077afii10097afii10069afii10107afii10101afii10043afii10078afii10024afii10073afii10089afii10092afii10147afii10087afii10081afii10029afii10083afii10026afii10019afii10032afii10046afii10072afii10021afii10030afii10098afii10038afii10017afii10040afii10042afii10105afii10052afii10057afii10025afii10034afii10053afii10832afii10058afii10018afii10044afii10110afii10020afii10095Rholenisafii10104afii10106afii10090afii10091afii10060afii10028afii10045afii10099afii10066afii10084afii10031afii10196afii10035afii10088afii10093Eth.swashafii10100uni0394afii10023afii10195uni2215uni021Aafii10108uni03BCuni00ADuni00A0uni03A9uni021Bafii10846afii61352afii10831Copyright 2000 Adobe Systems Incorporated. All Rights Reserved. U.S. Patents Des. 338,907 and 371,799.Minion is either a registered trademark or a trademark of Adobe Systems Incorporated in the United States and/or other countries.Minion Pro ItalicMinion Proq N s ^mTw6zgjTRC @ q
C
d
m
r$7
,
Q
c
!*D )d Gcw~!;FJ3%3@FP8ir3y1S_ju(/6:n . 9 C v !!/!5!`!h!!!!!"""@"g"t"|""""###W#\#h#n#v######$$ $&$,$3$:$K$U$r$$$$$$$$$% %%%5%D%]%h%o%v%%%%%%%%%%%& &&,&9&C&J&P&U&j&&&&&&&&&&&''''#'(':'L'Q'\'a'g'x'''''''''(((%(/(7(>(E(L([(j(w(~((((((((((((((())))!).)9)D)K)R)Y)`)f)k)o)t))))))))))))))**
****%*0*;*F*Q*\*g*r*}*****-
oFl\8Mgk^?ŜeQ[a`FpUI߹|{{|VsrocghpzvL##4/Jcݹ+!MWagpu
|;;.|;9hꖧovgtfstqon@Sm|}ĬD⋄DQnJs8*Tlb~wg8`F(;@§ŰY9kde:S!VtVl-ܲq
m
ބ}A98}@=
^98ԏڒ,`fhMhx{r/S#Qݟ9ʞJ+^VT\]xZ]Rmh
dn$d_JoDO(q
zm
ӇbjVy-}EVeF4)AKڑף
ڄ|>[tA_d}ʟɩ藿ΎwC{LZnXH;slz`Z?; :\o"T÷ķT`ź_j{xR{YvPwUBy
|s^`_ZNu[XUoaN{;iV`VsjaK]<_IZF"v,
b|bw`tgigxumjbisˎA{lW_ïknruxutnivry?y>x? rxǼiwi4wxηŻ6xyppvTyJyQ,|;7
^1؟svmdؓd
upՆ]oXy.]#m
vu|YWx.^h~_tWpy^Fy_pp͆SVQL
owÐˑ_Dm
{qtg`O_Rxo|TpgC]cwxz8REpzD掚˴k[uqlchkmXfjevrkpocjfq~z~|zhfsPfnwr
Wym{qhlb\2\)FWy:y1er}yo;ڕԑZhĚڰW-Änj~sypkWkuo_8lewߢۂ|ogYQZktY00=ZH<4 Eu{tzy{|wB/`J
aoAh{1~Ug^YoG=E)?XEݻd9N9&)^:<>